The Estée Lauder Companies Inc. (LON:0JTM)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	24,726	30,188	55,232	74,893	83,489	54,859
Market Cap Growth	-58.00%	-45.34%	-26.25%	-10.29%	52.19%	5.21%
Enterprise Value	29,822	35,710	59,078	78,941	85,058	58,089
Last Close Price	68.01	81.99	148.40	195.53	216.33	147.94
PE Ratio	-	97.82	69.77	38.08	40.18	99.31
PS Ratio	2.16	2.44	4.41	5.13	7.11	4.75
PB Ratio	7.35	7.18	10.94	14.15	16.60	17.14
P/TBV Ratio	-	-	-	-	-	346.55
P/FCF Ratio	-	26.48	96.41	45.50	38.51	40.99
P/OCF Ratio	-	16.17	40.55	29.94	31.76	29.79
EV/Sales Ratio	2.67	2.89	4.72	5.41	7.25	5.03
EV/EBITDA Ratio	13.60	18.77	29.67	22.40	32.09	26.52
EV/EBIT Ratio	29.90	28.58	42.04	26.98	39.03	34.23
EV/FCF Ratio	40.64	31.32	103.13	47.96	39.24	43.41
Debt / Equity Ratio	2.16	1.85	1.59	1.19	1.17	2.22
Debt / EBITDA Ratio	3.23	3.14	3.15	1.50	1.82	2.50
Debt / FCF Ratio	9.90	6.82	13.97	3.82	2.71	5.31
Asset Turnover	0.69	0.69	0.72	0.83	0.82	0.92
Inventory Turnover	1.81	1.72	1.55	1.59	1.68	1.75
Quick Ratio	0.89	0.90	0.88	0.97	1.26	1.20
Current Ratio	1.41	1.39	1.47	1.60	1.84	1.72
Return on Equity (ROE)	-15.98%	6.97%	15.72%	35.99%	52.70%	16.63%
Return on Assets (ROA)	3.88%	4.38%	5.04%	10.36%	9.46%	8.49%
Return on Capital (ROIC)	5.48%	6.22%	7.28%	15.26%	13.53%	12.75%
Return on Capital Employed (ROCE)	8.90%	9.90%	10.40%	23.60%	18.10%	16.70%
Earnings Yield	-2.73%	1.02%	1.43%	2.63%	2.49%	1.01%
FCF Yield	2.97%	3.78%	1.04%	2.20%	2.60%	2.44%
Dividend Yield	1.46%	2.55%	1.37%	0.98%	0.69%	0.76%
Payout Ratio	-	242.82%	91.95%	35.15%	26.24%	73.54%
Buyback Yield / Dilution	0.19%	0.03%	1.10%	0.90%	-0.35%	0.95%
Total Shareholder Return	1.65%	2.58%	2.46%	1.88%	0.34%	1.70%

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.